Hooo-Hooo Volume 9, Nr 4 | Page 12

WildLife Group of the SAVA your body, including some of the “good” bacteria that help you digest food, fight infection, and stay healthy. Bacteria that are tough enough to survive the drug will have a chance to grow and quickly multiply. These drug-resistant strains may even spread to other people,” explains Johan Oosthuyse, CEO of V-Tech, one of South Africa’s leading providers of pharmaceutical solutions to the animal health industry. “Over time, if more and more people take antibiotics when they aren’t necessary, drug-resistant bacteria will continue to thrive and spread. They may even share their drug-resistant traits with other bacteria. As a result, drugs may become less effective or not work at all against certain disease-causing bacteria.” Oosthuyse strongly believes this is making it even more vital to ensure that antibiotics (also known as antimicrobials) which are used to treat sick animals, especially those bred for food, are used responsibly to prevent increased antimicrobial resistance (AMR). He adds that South Africa is expected to play an important role in the global fight against AMR. “Even though there is conflicting evidence about the relationship between AMR in humans and in animals, there is a real concern globally that AMR will further limit the availability of antimicrobials that will effectively treat human diseases in the future. As a result, vets and other health officials, together with pharmaceutical companies like V-Tech, need to work together towards achieving the strategic objectives set out in the World Health Organisation’s AMR framework.” V-Tech has been promoting the responsible use of antimicrobials in the local meat and poultry industry for many years. It is the only company in South Africa to offer extensive surveillance in the use of antimicrobials on animals, working with industry leaders for the past eight years to ensure that meat and poultry eaten by South Africans is completely antimicrobial-free before it is packaged for consumption. This is done through a strict approach – firstly by testing the infected animals to ensure the right medicine is prescribed, then by formulating animal- or farm-specific medicine, and then by testing the animals to ensure the treatment is being effective and then that the antibiotic is withdrawn in time. “Antimicrobials for animal treatment should follow strict guidelines with minimum inhibitory concentration (MIC) diagnostics – by that we mean using the lowest possible concentration of an antimicrobial that will prevent the growth of bacteria, ensuring the drug used is specific to that bacterium and used only when absolutely necessary. This is becoming a worldwide trend. Personalised medicine means selecting the right drug at the right dose for the identified animal(s) or farm – this make